Docoh
Loading...

Jennifer Schranz

Jennifer Schranz is Chief Medical Officer of Nabriva Therapeutics Plc.

Person profile

Roles
Nabriva Therapeutics Chief Medical Officer
Address
King of Prussia, Pennsylvania
Employees
SEC CIK

Calendar

22 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 Feb 21 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 2.39 33 78.87 39,125
31 Jan 21 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 2.62 36 94.32 39,158
29 Jan 21 NBRV Nabriva Therapeutics Ordinary Shares Grant Acquire A No No 0 22,500 0 39,194
31 Dec 20 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 2.42 30 72.6 16,694
30 Nov 20 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 0.427 301 128.53 167,240
31 Oct 20 NBRV Nabriva Therapeutics Ordinary Shares Payment of exercise Dispose F No No 0.4955 301 149.15 167,541

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings